GlobeNewswire

LeoVegas wins three awards at Malta Gaming Awards

Dela

Against many strong competitors, LeoVegas won the awards "CSR of the Year", "Careers Program of the Year" and "Sportsbook of the Year".

"Winning these three awards really shows LeoVegas breadth as a company. I am particularly happy and proud that our efforts in responsible gaming, through LeoSafePlay, have been recognized through winning the CSR-award. It is an area we continue to explore and invest resources in. Besides leading the way into the mobile future, we also lead the way in Maltas i-Gaming sector." says Gustaf Hagman, Group CEO.

CSR of the Year - Corporate Social Responsibility of the Year
During the past year LeoVegas has made substantial efforts within responsible gaming, which has resulted in a new, dedicated portal called LeoSafePlay. The base of LeoSafePlay is a tool based on machine learning, to proactively discover players who can develop unhealthy gambling behaviour. The clients can get help identifying their behaviour and gambling that might be problematic through an anonymous test. As one of the few companies in the industry, LeoVegas offers a free tool (GamBan) to block all gaming sites and an insurance (LeoSafe) which pays for the clients first visit with a therapist specialized in gambling addiction. All information and tools are gathered in the portal www.leosafeplay.com, which is referred to clients, family members and other parties involved.

Also mentioned in the CSR award is LeoInitiative, with the purpose to improve the situation for lions around the world, LeoVegas' support for local help organizations and being main sponsor for the Maltese Pride Festival.

Careers Program of the Year
This award shows that LeoVegas has the best culture and the conditions to enable a sustainable and developing career path. With a strong team, LeoVegas offer the gaming industry's most attractive career opportunities and an equal work place.

Sportsbook of the Year
LeoVegas Sports has evolved tremendously during the last year. LeoVegas Sport was launched in several of the major markets and today offer the possibility to bet on over 130 000 sports events. A function that is the base for the award is instant betting, which makes it possible for the client to bet in real time, for example in tennis, where the client can place a bet up until the ball is served.

Malta Gaming Awards is held annually to highlight significant efforts in the iGaming sector on Malta. A panel consisting of 20 independent professionals are judges and the process is audited by KPMG.

För ytterligare information, vänligen kontakta:

Gustaf Hagman, Group CEO och medgrundare: +46 70-880 55 22, gustaf.hagman@leovegas.com

Philip Doftvik, Head of Investor Relations: +46 73 512 07 20, philip.doftvik@leovegas.com

Besöksadress: Sveavägen 59, Stockholm
Organisationsnummer: 556830-4033

Om mobilspelsbolaget LeoVegas
LeoVegas passion är "Leading the way into the mobile future" Verksamheten präglas av prisbelönt innovation och stark tillväxt. LeoVegas teknikutveckling sker i Sverige medan den operativa verksamheten är baserad på Malta. Det svenska moderbolaget LeoVegas AB (publ) investerar i företag som erbjuder spel via mobila enheter och datorer samt företag som utvecklar relaterad teknik. LeoVegas har fått stor uppmärksamhet internationellt och har vunnit ett flertal utmärkelser. Bland annat "Nordic Operator of the year", "Mobile Marketing Campaign of the year", "Innovation in Mobile and Tablet of the year" vid internationella EGR Awards. LeoVegas är utvecklat "Mobile First" och ligger i framkant med den senaste teknologin på marknaden för mobilspel. Med bas i en framstående spelupplevelse, långsiktiga kundrelationer och etableringen av ett starkt varumärke har Bolaget med innovativ, effektiv och datadriven marknadsföring attraherat en kontinuerligt växande kundbas. Mobilspelsbolaget LeoVegas har sedan start visat stark tillväxt varje kvartal. Bolagets aktie är listad på First North Premier och Avanza Bank AB är Bolagets Certified Adviser. Mer information om LeoVegas återfinns på www.leovegasgroup.com eller www.leovegas.com .




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: LeoVegas AB via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum